Ignite Creation Date:
2024-05-06 @ 2:50 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04449653
Status:
UNKNOWN
Last Update Posted:
2020-06-29
First Post:
2020-05-26
Brief Title:
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
Sponsor:
Progentec Diagnostics Inc
Organization:
Progentec Diagnostics Inc
Study Overview
Official Title:
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
Status:
UNKNOWN
Status Verified Date:
2020-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OASIS
Brief Summary:
OASIS A mobile study to measure and predict lupus SLE disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers like activity level and heart rate variability can be used to predict changes in lupus disease activity You may receive a Withings Steel HR smartwatch as part of this study The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None